posting velocity //
Opens vs closes per day
Based on 5 events over 25 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
Showing: Israel. Click another pill to switch.
Open now
3
Total active openings across all sites
Δ 28-day
+3
Opens minus closes in the last 28 days
Δ 90-day
+3
Opens minus closes in the last 90 days
posting velocity //
Based on 5 events over 25 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
5.2 days
25th pct
5.2 days
75th pct
5.2 days
Based on 1 closed jobs and 3 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Still collecting — median tracking age is ~3.2 days (need 14+). 0% of closures were within 3 days, which often reflects feed churn rather than hires.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
0.4%
1 / 275 of closed jobs reposted within 60 days
company intel · ai-generated
Updated 2d ago
ZOLL Medical Corporation, founded in 1980 by Dr. Paul Zoll, is a Massachusetts-based manufacturer of medical devices and software solutions. In 2012, the company was acquired by the Japanese conglomerate Asahi Kasei for $2.21 billion and operates as its subsidiary.
ZOLL focuses on acute critical care and related diagnostics. Its primary domains include resuscitation, temperature management, and sleep apnea diagnosis. The company sells its devices to hospitals, emergency medical services (EMS) providers, and home care patients.
The company develops professional defibrillators (such as the X Series and R Series) and automated external defibrillators (AEDs) for public and medical use. Another key product is the LifeVest, a wearable defibrillator for patients at risk of sudden cardiac arrest. Additionally, ZOLL manufactures ventilators and the WatchPAT home sleep apnea diagnostic device.
ZOLL competes globally with medical technology firms like Stryker (which acquired Physio-Control) and Philips in the resuscitation and critical care markets. In the sleep apnea diagnostics space, it competes with companies such as ResMed.
ZOLL maintains a significant R&D and operational footprint in Israel, built primarily through acquisitions. In 2015, ZOLL acquired Kfar Saba-based Kyma Medical Technologies to integrate its RF-based fluid monitoring technology for heart failure patients. In 2021, the company expanded its Israeli operations by acquiring Caesarea-based Itamar Medical for approximately $538 million. The Caesarea site continues to serve as a key center for ZOLL's sleep diagnostic operations and development of the WatchPAT device.
key people & leadership
1 key people, sourced from public records — with a per-row confidence score.
Jon Rennert
CEO
news feed
No recent news about this company.
hiring signal · from our data
From our job data · always current
3 open roles in Israel
Live openings we track — Israel first, plus worldwide when we have them.
Top roles